VSIG8-Fc-OX40L

N/A

Report date: 2024/07/30 17:03:53

Base Information

Drug NameVSIG8-Fc-OX40L

Drug Alias NameVSIG8-Fc-OX40L

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists

TargetsTumor necrosis factor receptor superfamily member 4

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesShattuck Labs Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesShattuck Labs Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A